Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 41-50 of 94 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015ADVAN-style analytical solutions for common pharmacokinetic modelsAbuhelwa, A.; Foster, D.; Upton, R.
2015Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioidsPeacock, A.; Bruno, R.; Cama, E.; Kihas, I.; Larance, B.; Lintzeris, N.; Hordern, A.; White, N.; Ali, R.; Degenhardt, L.
2015Interval Training Versus Continuous Exercise in Patients with Coronary Artery Disease: A Meta-AnalysisElliott, A.; Rajopadhyaya, K.; Bentley, D.; Beltrame, J.; Aromataris, E.
2015Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of mycophenolic acid in renal transplant recipientsDom, Z.I.M.; Westley, I.S.; Coller, J.K.; Somogyi, A.A.; Sallustio, B.C.; 2015 Golden Helix Symposium - Next Generation Pharmacogenomics (11 Mar 2015 - 13 Mar 2015
2015Transcription factor-mediated reprogramming: Epigenetics and therapeutic potentialFiras, J.; Liu, X.; Lim, S.M.; Polo, J.M.
2015Sodium content and labelling of processed and ultra-processed food products marketed in BrazilMartins, C.; De Sousa, A.; Veiros, M.; González-Chica, D.; Da Costa Proença, R.
2015Frailty syndrome - medicolegal considerationsByard, R.W.
2015Effect of long-term (2 years) exposure of mouse brains to global system for mobile communication (GSM) radiofrequency fields on astrocytic immunoreactivityCourt-Kowalski, S.; Finnie, J.; Manavis, J.; Blumbergs, P.; Helps, S.; Vink, R.
2015Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosisCottle, D.L.; Ursino, G.M.A.; Ip, S.C.I.; Jones, L.K.; Ditommaso, T.; Hacking, D.F.; Mangan, N.E.; Mellett, N.A.; Henley, K.J.; Sviridov, D.; Nold-Petry, C.A.; Nold, M.F.; Meikle, P.J.; Kile, B.T.; Smyth, I.M.
2015A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemiaBartley, P.; Latham, S.; Budgen, B.; Ross, D.; Hughes, E.; Branford, S.; White, D.; Hughes, T.; Morley, A.